BOCCUZZI, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 3.670
EU - Europa 2.157
AS - Asia 1.228
AF - Africa 30
OC - Oceania 11
SA - Sud America 11
Continente sconosciuto - Info sul continente non disponibili 7
Totale 7.114
Nazione #
US - Stati Uniti d'America 3.616
CN - Cina 782
SE - Svezia 325
UA - Ucraina 282
IE - Irlanda 274
IT - Italia 248
DE - Germania 207
FR - Francia 206
FI - Finlandia 201
KR - Corea 162
GB - Regno Unito 128
SG - Singapore 104
PL - Polonia 90
AT - Austria 71
VN - Vietnam 65
CA - Canada 48
JP - Giappone 43
DK - Danimarca 42
BE - Belgio 24
IN - India 22
SN - Senegal 22
AU - Australia 11
GR - Grecia 11
NL - Olanda 11
ES - Italia 10
RU - Federazione Russa 10
TW - Taiwan 9
UZ - Uzbekistan 9
EU - Europa 7
TH - Thailandia 7
HK - Hong Kong 6
MX - Messico 5
RO - Romania 5
BR - Brasile 4
CL - Cile 4
PH - Filippine 4
TR - Turchia 4
BG - Bulgaria 3
CO - Colombia 3
IR - Iran 3
MU - Mauritius 3
CZ - Repubblica Ceca 2
HR - Croazia 2
HU - Ungheria 2
ID - Indonesia 2
MY - Malesia 2
NG - Nigeria 2
PK - Pakistan 2
BY - Bielorussia 1
CH - Svizzera 1
EG - Egitto 1
GL - Groenlandia 1
LU - Lussemburgo 1
MA - Marocco 1
MO - Macao, regione amministrativa speciale della Cina 1
SA - Arabia Saudita 1
ZA - Sudafrica 1
Totale 7.114
Città #
Chandler 671
Beijing 614
Ann Arbor 274
Dublin 273
Ashburn 228
Houston 216
Jacksonville 212
Fairfield 147
Villeurbanne 147
Medford 112
Nyköping 102
Princeton 98
Wilmington 98
Dearborn 97
Woodbridge 94
Warsaw 89
Torino 80
Vienna 69
Singapore 64
Seattle 62
Cambridge 54
Dong Ket 46
Milan 42
Pisa 40
Boardman 38
Boston 38
New York 27
Redwood City 27
Fremont 26
Toronto 25
Brussels 23
Verona 22
Lachine 18
Shanghai 14
Norwalk 13
Nanjing 12
Washington 12
Zhengzhou 11
Chicago 10
Kunming 10
Detroit 9
Guangzhou 9
Phoenix 9
San Diego 9
Tokyo 9
Xian 8
Athens 7
Hefei 7
Nanchang 7
Wuhan 7
Fuzhou 6
Seoul 6
Shenyang 6
Des Moines 5
Helsinki 5
San Antonio 5
Chengdu 4
Falls Church 4
Hangzhou 4
Hong Kong 4
London 4
Los Angeles 4
Mazzè 4
Messina 4
Moscow 4
Mountain View 4
Silver Spring 4
Tappahannock 4
Turin 4
West Covina 4
Almachar 3
Barnsley 3
Bogotá 3
Changsha 3
Greenfield 3
Jinan 3
Madrid 3
Mexico 3
Nanning 3
Queens 3
Saint-Augustin-de-Desmaures 3
San Mateo 3
Santiago 3
Taipei 3
Ardabil 2
Bangkok 2
Bologna 2
Buffalo 2
Buggingen 2
Canberra 2
Catania 2
Charlestown 2
Cheongju-si 2
Chinchvad 2
Chongqing 2
Cremona 2
Denizli 2
Edinburgh 2
Fort Worth 2
Guiyang 2
Totale 4.499
Nome #
AGEs/RAGE complex upregulates BACE1 via NF-kappaB pathway activation 410
Dysregulation of SREBP2 induces BACE1 expression. 277
Advanced glycation end-products promote hepatosteatosis by interfering with SCAP-SREBP pathway in fructose drinking mice 255
Cardiac impairment in rabbits fed a high-fat diet is counteracted by dehydroepiandrosterone supplementation 196
Fructose-derived advanced glycation end-products induce a negative crosstalk between lipogenesis and muscle reprogramming in mice through SREBP-1c 186
Fructose-derived advanced glycation end-products drive lipogenesis and skeletal muscle reprogramming via SREBP-1c dysregulation in mice 175
Valproic Acid, a Histone Deacetylase Inhibitor, in Combination with Paclitaxel for Anaplastic Thyroid Cancer: Results of a Multicenter Randomized Controlled Phase II/III Trial 157
Epigenetics modifications and therapeutic prospects in human thyroid cancer. 154
Oxidative stress and kidney dysfunction due to ischemia/reperfusion in rat: attenuation by dehydroepiandrosterone. 152
Sex hormone-binding globulin antagonizes the anti-apoptotic effect of estradiol in breast cancer cells 149
Sex hormone-binding globulin selectively modulates estradiol-regulated genes in MCF-7 cells 125
Cytotoxic activity of the histone deacetylase inhibitor panobinostat (LBH589) in anaplastic thyroid cancer in vitro and in vivo. 122
Dehydroepiandrosterone pretreatment protects rats against the pro-oxidant and necrogenic effects of carbon tetrachloride. 109
Adrenal androgen action in breast cancer. 108
Oxygen free radical scavenger properties of dehydroepiandrosterone. 100
Dehydroepiandrosterone inhibits the growth of DMBA-induced rat mammary carcinoma via the androgen receptor. 97
Opposite effects of dehydroepiandrosterone on the growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas. 96
Dehydroepiandrosterone antiestrogenic action through androgen receptor in MCF-7 human breast cancer cell line. 92
Dehydroepiandrosterone protects bovine retinal capillary pericytes against glucose toxicity. 92
AGEs up-regulates BACE1 through their interaction with RAGE and NFkB activation. 89
EFFECTS OF PANOBINOSTAT, A NOVEL DEACETYLASE INHIBITOR, IN PRIMARY CULTURES OF ANAPLASTIC THYROID TUMOURS 88
Dihydrotestosterone affects the growth of hormone-unresponsive breast cancer cells: an indirect action. 85
NT2 neurons, a classical model for Alzheimer's disease, are highly susceptible to oxidative stress 85
5-En-androstene-3 beta,17 beta-diol inhibits the growth of MCF-7 breast cancer cells when oestrogen receptors are blocked by oestradiol. 84
Molecular mechanisms of the D327N SHBG protective role on breast cancer development after estrogen exposure 84
Dehydroepiandrosterone administration counteracts oxidative imbalance and advanced glycation end product formation in type 2 diabetic patients 82
EFFETTO DELLE ONDE D’URTO SUL DIFFERENZIAMENTO DI CELLULE STAMINALI MESENCHIMALI IN CELLULE OSTEOPROGENITRICI 81
THE DEACETYLASE INHIBITOR PANOBINOSTAT IS A CYTOTOXIC DRUG AND INDUCER OF IODINE UPTAKE IN ANAPLASTIC THYROID CANCER PRIMARY CULTURES 78
Valproic acid restores ER-alpha and antiestrogen sensitivity to ER-alpha-negative breast cancer cells 77
Dehydroepiandrosterone protects tissues of streptozotocin-treated rats against oxidative stress. 75
Modulations of the calcineurin/NF-AT pathway in skeletal muscle atrophy 74
THE DEACETYLASE INHIBITOR PANOBINOSTAT INHIBITS THE INVASIVE ACTIVITY OF ANAPLASTIC THYROID CANCER CELLS 74
The pan-DAC inhibitor LBH589 is a multi-functional agent in breast cancer cells: cytotoxic drug and inducer of sodium-iodide symporter (NIS) 73
Influence of dehydroepiandrosterone and 5-en-androstene-3 beta, 17 beta-diol on the growth of MCF-7 human breast cancer cells induced by 17 beta-estradiol. 72
Histone Deacetylase Inhibition Modulates E-CadherinExpression and Suppresses Migration and Invasion ofAnaplastic Thyroid Cancer Cells 72
Indirect growth inhibition of the MDA-MB-231 hormone-independent breast cancer cell line by dihydrotestosterone. 71
Dehydroepiandrosterone administration prevents the oxidative damage induced by acute hyperglycemia in rats. 70
Pro-inflammatory cytokines and oxidative stress/antioxidant parameters characterize the bio-humoral profile of early cachexia in lung cancer patients 68
LOOKING FOR THE MOLECULAR BRIDGE BETWEEN SEX HORMONE-BINDING GLOBULIN (SHBG) AND BREAST CANCER CELLS 68
Effects of the histone deacetylase inhibitor valproic acid on the sensitivity of anaplastic thyroid cancer cell lines to imatinib 68
AROMATASE FAILS TO MEDIATE THE PROLIFERATIVE EFFECTS OF ADRENAL ANDROGENS ON CULTURED MCF-7 BREAST CANCER CELLS. 67
Breast duct fluid dehydroepiandrosterone sulphate in fibrocystic disease. 67
Ectopic secretion of LH by an endocrine pancreatic tumor 67
Dehydroepiandrosterone in diabetic rats: protection against NFkB activation. 67
Anaplastic thyroid carcinoma: clinical outcome of 30 consecutive patients referred to a single istitution in the past five years 67
Dehydroepiandrosterone prevents the decrease in bovine retinal capillary pericytes number induced in vitro by high glucose 66
Oxidative stress and cardiac fribiosis in diabetics rats 66
Oxidative and nitrosative stress in brain mitochondria of diabetic rats 66
ADRENAL ANDROGEN ACTION IN BREAST CANCER 65
Dehydroepiandrosterone concentration in breast cancer tissue is related to its plasma gradient across the mammary gland. 62
High energy shock waves activate 5'-aminolevulinic Acid and increase permeability to Paclitaxel: antitumor effects of a new combined treatment on anaplastic thyroid cancer cells 61
Oxidative Stress Triggers Cardiac Fibrosis in the Heart of Diabetic Rats 61
Dehydroepiandrosterone and diabetic complications 61
Pro-oxidant effect of dehydroepiandrosterone in rats is mediated by PPAR activation. 60
Effect of oxidative stress on muscle wasting in diabetic rats. 59
Valproic acid induces apoptosis and cell cycle arrest in poorly differentiated thyroid cancer cells 58
Valproic acid, a histone deacetylase inhibitor, enhances sensitivity to doxorubicin in anaplastic thyroid cancer cells 58
Dehydroepiandrosterone modulates nuclear factor-kappaB activation in hippocampus of diabetic rats. 58
Oxidative stress-dependent impairment of cardiac-specific transcription factors in experimental diabetes 57
Dehydroepiandrosterone prevents lipid peroxidation and cell growth inhibition induced by high glucose concentration in cultured rat mesangial cells. 56
Effect of synthetic luteinizing hormone releasing hormone (LH-RH) on the release of gonadotropins in Cushing's disease. 56
Diabetes and muscle wasting: regulatory effect of dehydroepiandrosterone. 56
EFFECTS OF THE pan-DAC INHIBITOR LBH589 IN ESTROGEN SENSITIVE AND INSENSITIVE BREAST CANCER CELLS. 56
THE pan-DAC INHIBITOR LBH589 INDUCES E-CADHERIN EXPRESSION IN ESTROGEN-RECEPTOR NEGATIVE BREAST CANCER CELLS. 56
Selective up-regulation of tumor necrosis factor receptor I in tumor-bearing rats with cancer-related cachexia 55
SREBP-1c in NAFDL induced by Western-type high-fat diet plus fructose in rats 55
Up-regulation of advanced glycated products receptors in the brain of diabetic rats is prevented by antioxidant treatment 55
Pioglitazone improves lipid and insulin levels in overweight rats on a high cholesterol and fructose diet by decreasing hepatic inflammation. 54
Insulin reduces cerebral ischemia/reperfusion injury in the hippocampus of diabetic rats: a role for glycogen synthase kinase-3beta 53
Valproic acid is a selective antiproliferative agent in estrogen-sensitive breast cancer cells 52
Dehydroepiandrosterone prevents the decrease in bovine retinal capillary pericytes number induced in vitro by high glucose. I 50
THE pan-DAC INHIBITOR LBH589 INDUCES NIS (SODIUM-IODIDE SYMPORTER) EXPRESSION IN BREAST CANCER 50
Protective effect of dehydroepiandrosterone against copper-induced lipid peroxidation in the rat 49
THE ANTIANDROGEN FLUTAMIDE INHIBITS GROWTH OF MCF-7 HUMAN BREAST CANCER CELL LINE. 47
Growth inhibition of DMBA-induced rat mammary carcinomas by the antiandrogen flutamide. 46
Sex Hormone-Binding Globulin (SHBG), estradiol and breast cancer. 46
EFFECT OF CYPROTERONE ACETATE THERAPY ON GONADOTROPIN RESPONSE TO SYNTHETIC LUTEINIZING HORMONE RELEASING HORMONE (LH RH) IN GIRLS WITH IDIOPATHIC PRECOCIOUS PUBERTY. 45
Valproic acid induces the expression of the Na+/I- symporter and iodine uptake in poorly differentiated thyroid cancer cells 44
Role of glucose-6-phosphate dehydrogenase inhibition in the antiproliferative effects of dehydroepiandrosterone on human breast cancer cells. 44
Inhibitory effect of hydroxyflutamide plus tamoxifen on oestradiol-induced growth of MCF-7 breast cancer cells. 43
Ultrasound screening for thyroid carcinoma in childhood cancer survivors: a case series 43
Muscle wasting in diabetic and in tumor-bearing rats: Role of oxidative stress 42
Oxidative stress and eicosanoids in the kidneys of hyperglycemic rats treated with dehydroepiandrosterone. 42
Oxidative stress impairs skeletal muscle repair in diabetic rats 42
Impulsive and basal ACTH secretion phases in normal subjects, in obese subjects with signs of adrenocortical hyperfunction and in hyperthyroid patients. 41
Protective effect of dehydroepiandrosterone against lipid peroxidation in a human liver cell line. 41
Prevention of carbon tetrachloride-induced lipid peroxidation in liver microsomes from dehydroepiandrosterone-pretreated rats. 39
Oxidative derangement in rat synaptosomes induced by hyperglycaemia: restorative effect of dehydroepiandrosterone treatment. 38
Once-a-day neurally stimulated and basal ACTH secretion phases in man and their response to corticoid inhibition. 37
Possibile ruolo terapeutico del deidroepiandrosterone nell' insufficienza surrenalica e nell' invecchiamento 37
Emerging molecular therapies of advanced thyroid cancer. 34
Valproic acid enhances tubulin acetylation and apoptotic activity of paclitaxel on anaplastic thyroid cancer cell lines 32
Totale 7.399
Categoria #
all - tutte 21.250
article - articoli 0
book - libri 0
conference - conferenze 3.249
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.499


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.104 26 31 88 138 110 201 137 40 121 82 67 63
2020/2021790 66 36 70 46 67 53 64 27 130 71 47 113
2021/2022892 47 35 48 43 40 30 57 47 41 44 180 280
2022/20231.509 180 135 66 185 129 356 109 95 147 17 63 27
2023/2024620 79 115 38 28 57 119 18 37 2 8 46 73
2024/20258 8 0 0 0 0 0 0 0 0 0 0 0
Totale 7.399